Colour Masterbatch CAS: 9002-88-4
Related Insights
South Korea's Small Cracker Shutdowns: What Asia's Petrochemical Consolidation Means for Buyers
South Korea's planned petrochemical restructuring is expected to close smaller stand-alone naphtha crackers, signalling a broader wave of capacity consolidation across Asia. Procurement teams should assess how fewer production assets may influence polymer supply, feedstock pricing and regional sourcing strategies.
Adhesive Raw Materials and the Velogy Transition: What EVA, VAM and Acrylic Acid Buyers Need to Know
The transfer of LyondellBasell's European assets to Velogy has introduced fresh uncertainty for buyers of adhesive raw materials. Procurement teams sourcing European EVA, VAM and acrylic acid should closely monitor production plans at the French and German cracker sites.
ESG Ratings in a Crisis: Hormuz as a Test of Chemical Company Supply Chain Resilience
The sudden disruption in the Hormuz Strait has spotlighted the fragility of chemical supply chains. Companies now must rethink sourcing, diversify origins, and embed measurable resilience into ESG reports to regain investor trust. Learn how to turn crisis into ESG growth.
The Contradiction Index: Tracking the Gap Between Diplomatic Signals and Physical Reality in Hormuz
July 1 reveals the biggest contradiction of the Hormuz crisis so far: diplomacy suggests progress, but physical shipping data shows continued disruption. For chemical procurement professionals, understanding the gap between political signals and operational reality has become essential for making correct supply chain decisions.
Methanol Supply Update: What AIS Shipping Data Means for Q3 Buyers
Methanol supply has remained active through recent Gulf disruptions, with AIS vessel tracking showing continued commercial movement. Buyers should separate headline risk from physical flow data when planning Q3 procurement.
Drug Shortage Risk Monitoring: July 1 Refresh of the High-Risk API List
The July 1, 2026 pharmaceutical supply chain review highlights the latest drug shortage risks. While logistics for Indian and Chinese APIs continue improving, critical antibiotics, sterile injectables, and GLP-1 manufacturing inputs remain key procurement priorities.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.